Radioprotectors / Chromone / 2-Iminothiazolidine / γ γ γ γ -Irradiation A series of 2-imino-3-[(chromone-2-yl) carbonyl]thiazolidines substituted at the C-5 and / or C-7 positions of a chromone ring were synthesized. The in vivo toxicity and radioprotective efficacy of these agents were evaluated in male NMRI mice against cobalt-60 γ -rays. The LD 50 values as determined by a Probit analysis, were 659, 1216 and 790 mg/kg for compounds, 2, 3 and 4, respectively. For studying radioprotective effects, one half of the toxic LD 50 values were used, namely 330, 605 and 395 mg/kg for compounds 2, 3 and 4, respectively. The dose reduced factor (DRF) was determined by dividing the LD 50/30 values obtained from the radiation survival curve in the presence of a radioprotective agent by the LD 50/30 value obtained from a control radiation survival curve. A compound with a hydroxyl group substituent at the C-5 position afforded better radioprotective activity than those without this substituent. The radioprotective effect of chromone having a hydroxyl group at only the C-7 position was similar to that of the unsubstituted chromone. The most active compound has hydroxyl groups at the C-5 and C-7 positions of the chromone ring; it had a DRF of 1.48.
INTRUDUCTION
A radioprotector is a chemical or biological compound capable of modifying the normal response of a biological system to radiation-induced toxicity or lethality. The aminothiols, such as S -2-(3-aminopropylamino)ethyl phosphorothioic acid (WR-2721), are potent radioprotectors 1) . Using on in vivo electron spine resonance study, Miura Y. et al recently showed that WR 2721 has powerful radioprotective activity and lower protective effects compared to 5-HT and Trolox 2) . However, its toxicity has limited its applications in medicine or in hazardous radiation environments 3) . For this reasons the search for more effective and less toxic radioprotectans has spurred interest in the development of different compounds. 2-Aminothiazoline (2-AT, Fig. 1 ) showed protective activity in both mice and rats 4) . Several organic and inorganic salts as well as derivatives of 2-AT were synthesized as potential protective agents against radiation injury 4, 5) . We recently reported on the radioprotective activity of 2-iminothiazolidine derivatives against γ -radiation 6) . The percentage survival of mice at 30 days for the latter compared to control mice was 10 to 30% when injected before γ -irradiation; these compounds had significant protective effects compared to the control 6) . Some natural antioxidants (e.g. flavonoids) are widely disturbed in fruits and vegetables. Flavonoids are benzo-γ -pyrone derivatives which are able to suppress the formation of free radicals and have antioxidant effects [7] [8] [9] [10] [11] [12] . Some of these compounds are currently being used as antioxidant food additives 13) . The radioprotective effects of structurally different flavonoids have been investigated against γ -irradiation in mice, and have shown protective activity [14] [15] [16] . Along this line, we have incorporated 2-AT with chromone having a hydroxyl moiety at the C-5 and / or C-7 positions. In this paper the toxicity and radioprotective activity of three 2-imino-3-[(chromone-2-yl)carbonyl]thiazolidines ( Fig. 1: 2, 3 and 4) , which are structurally similar to flavonoids, against gamma radiation are reported.
MATERIALS AND METHODS

Chemicals
All chemicals were purchased from Sigma-Aldrich (Steinheim-Germany). 2-AT was prepared according to our previously reported method 6) . Melting points (m.p.) were determined using a Kofler hot stage apparatus. 1 H NMR spectra were recorded on a Bruker FT-80 Spectrometer. TMS was used as an internal standard. Infrared spectra were acquired on a Nicolet 550-FT spectrometer. Mass spectra were measured with a Finnigan TSQ-70 spectrometer at 70 eV. The purity of all compounds was confirmed by TLC.
Preparation of 4-oxo-4H-1-benzopyran 2-carboxylic acid (8)
A mixture of 2-hydroxyacetophenone (1g, 7.34 mmol) and diethyl oxalate (2.5 ml, 18.4 mmol) was added to sodium (0.5 g, 2.17 mmol) in absolute ethanol (10 ml). The mixture was heated at 50 ° C for 3 h, cooled, added to 25% sulfuric acid (25 ml) and heated under reflux for 1.5 h. After the reaction mixture was cooled, an insoluble solid was collected. (10) To a stirred solution of 2, 4, 6-trihydroxyacetophenone monohydrate (7.2 g, 12 mmol) in 25 ml of dry pyridine, cooled in an ice bath, ethoxalyl chloride (7.5 ml) was added dropwise. After the mixture was allowed to come to room temperature it was stirred overnight. A slurry was poured into water and extracted five times with CHCl 3 (3 × 50 ml). The combined CHCl 3 layer was washed with 10% HCl, followed by water. The solvent was removed under reduced pressure. After the residue was taken up in 50 ml of ethanol, 100 ml of 5% Na 2 CO 3 was added and mixture was stirred at 60-70 ° C for 2 h. The ethanol was removed in vacuo and the residue was acidified. The precipitate was collected and recrystallized from ethyl acetate-methanol (90:10) to give 0.9 g (34%) of compound 10; m.p.=305-308 ° C. Anal. Calcd for C 10 H 6 O 6 : C, 54.05; H, 2.70. Found: C, 53.86; H, 2.88 (2) N-N ′ -carbonyldiimidazole (1.27 g, 7.9 mmol) was added to a stirred solution of compound 8 (1 g, 5.3 mmol) in dry DMF (5 ml). After the mixture was stirred at 40-45 ° C for 1 h, 2-AT (0.64 g, 6.3 mmol) was added. Following further stirring overnight, the mixture was filtered and the filtrate was added to water (40 ml). Then, after 24 h at 0 ° C the solid was collected and recrystallized from n-hexane-chloroform (60:40) 
Preparation of 2-imino-3-[(4-oxo-4H-1-benzopyrane-2-yl)carbonyl]thiazolidine
Preparation of 2-imino-3-[(7-hydroxy-4-oxo-4H-1-benzopyran-2-yl) carbonyl]thiazolidine (3)
This compound was prepared in a similar way to compound 2 in 80% yield, and then recrystallized from THF-MeOH (30:70); m.p.=272-274 ° C; IR (KBr), ν (cm 
Preparation of 2-imino-3-[(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl) carbonyl]thiazolidine (4)
After compound 10 (1g, 4.5 mmol) was dissolved in dry THF (30 ml), N, N ′ -carbonyldiimidazole (1.45 g, 9 mmol) was added under argon. The mixture was heated at 60-70 ° C for 4 h. Following coolding, 2-AT (0.7 g, 6.75 mmol) in dry THF (15 ml) was added. After further stirring for 24 h, the resulting precipitate was filtered and recrystallized from ethanol to give compound 4 (0.7 g, 50%); m.p.=256-258 ° C; IR (KBr), ν (cm 
Animals
Eight-week old male NMRI mice (Pasteur Institute of Iran) weighing 28 ±3 g were used. A standardized pellete diet was given and tap water was ad libitum. The animals were housed in groups of seven for one week in a quarantine facility. All of the mice were kept under controlled lighting conditions (light: dark, 12:12h) and temperature (22±1°C) in the university animal house. Experiments were conducted according to principles outlined in " The Guide for The Care and Use of Laboratory Animals" prepared by Tehran University of Medical Sciences.
Toxicity studies
For toxicity studies the compounds were suspended in sterile distilled water having 0.2% polysorbate 80 (Tween 80) and were injected intraperitoneally (i. p.) in mice. Male NMRI mice were injected with a geometric progression of doses through the doseresponse range for lethal toxicity. Ten animals were used for each subgroup dose, and four doses were used for determining of each LD 50 . Death observations were analyzed by Probit analysis to determine the toxic LD 50 17) (Fig. 2) .
Radioprotective effect studies Whole-body irradiation was performed with a cobalt-60 γ-radiation source (Teratron 780, Canada). Mice were placed in ventilated plexiglass cages and irradiated. in groups of ten mice simultaneously. The source-to-skin distance was 80 cm with a dose rate of 77.5 cGy/min at room temperature (23±2°C). The mice were injected the compounds, which had been suspended in sterile distilled water having 0.2% Tween 80. For radioprotective studies, one half of a dose of LD 50 was administered 30 min before wholebody irradiation with a geometric progression of of gamma-rays doses. The control received an equal volume of sterile distilled water having 0.2% Tween 80 in the same manner. Ten mice were used for each subgroup dose of γ-rays. A total of 40 mice were used for each compound. Survival was monitored on a daily basis, and the number of animals 30 days post irradiation was recorded. The LD 50/30 and 95% confidence limits were determined from Probit curve fitting of the 30-day mortality data, and were fitted to Probit curves 17) . Each DRF was computed as the ratio of the radiation LD 50/30 value with the radioprotector to that without a radioprotector.
Statistical analysis
The LD 50 values were determined using the Probit statistical analysis 17) ; the values were expressed as the mean ± 95% confidence limits. The significance of the difference between the mean values obtained for various study end points was calculated using the student's t test. The values were considered to be significantly different if p < 0.05.
RESULTS
Chromone 2-carboxylic acids were synthesized according to Fig. 1 . Compounds 8 and 9 were prepared from 2-hydroxyacetophenone (5) or 2, 4-dihydroxycetophenone (6) and subsequent addition of 25% sulfuric acid, respectively. 5, 7-Dihydroxychromone-2-carboxylic acid (10) was prepared from 2, 4, 6-trihydroxyacetophenone (7) and ethoxalyl chloride in dry pyridine. 2-Imino-3-[(chromone-2-yl)carbonyl] thiazolidines were prepared from chromone 2-carboxylic acids (8, 9, 10) , N, N ′ -carbonyldiimidazole and 2-AT. The final products were purified by recrystallization. The toxicity effects of compounds 2, 3 and 4 were determined in vivo against male NMRI mice. Suspensions of compounds 2, 3 and 4 in sterile distilled water were injected i.p. in mice. These compounds showed a concentration-dependent effect on the survival in mice. The LD 50 values for these compounds were determined by the Probit analysis method 17) , and were found to be 659, 1216 and 790 mg/kg for compounds 2, 3 and 4, respectively (Table1). To evaluate the of radioprotective activity, one half of the toxic LD 50 values were used, namely 330, 605 and 395 mg/kg for compounds 2, 3 and 4. The compounds were evaluated in vivo for their radioprotective effects using male NMRI mice against cobalt-60 gamma rays. We found that the radiation dose for the LD 50/30 for control mice to be 654 cGy ( Table 1 ). The LD 50/30 values for compounds 2, 3 and 4 were 767, 771 and 968 cGy when these compounds were injected 30 minutes prior to gamma radiation. The dose reduced factor (DRF) was calculated from the radiation-survival curve generated for each compound tested (Table 1, Fig. 2 ). Compounds 2, 3 and 4 had DRF values of 1.17, 1.18 and 1.48, respectively. Although the radioprotective effects of compounds 2 and 3 were the same, compound 4 had a DRF of 1.48, more than that of compounds 2 and 3. The radioprotective effects of new synthesized compounds were compared to WR-2721. WR-2721 had a DRF of 1.63 when injected 30 minutes before irradiation (Table 1 and Fig. 2 ).
DISCUSSION
Flavonoids exhibit radioprotective activity in vivo and in vitro [14] [15] [16] . 2-AT and its derivatives showed protective activity in mice and rats against gamma radiation 4, 5, 6) . Along this line we have synthesized compounds having 2-AT and chromone containing a hydroxyl moiety at the C-5 and / or C-7 positions. The hydroxyl moiety was selected because the hydroxyl group is important for the antioxidant activity of flavonoids 7, 11, 14) . The three 2-imino-3-[(chromone-2-yl)carbonyl]thiazolidines prepared in this study were structurally similar to flavonoids. The LD 50 values obtained for compound 2 were lower than those of compounds 3 and 4 ( Table 1 ). The data indicated that apparently the substitution of a hydroxyl group at the 7-position of the chromone ring reduced the toxicity. However, the presence of two hydroxyl groups at the C-5 and C-7 positions of the chromone ring reduced the LD 50 value. All compounds were less toxic than 2-AT (LD 50 150 mg/kg) in mice 18) . To evaluate the radioprotective activity, one half of the toxic LD 50 values were used, namely 330, 605 and 395 mg/kg for compounds 2, 3 and 4 respectively, and 300 mg/kg for WR-2721. The dose reduced factor (DRF) was calculated from the radiation-survival curve generated for each compound tested (Table 1 and Fig. 2) . The higher was the DRF value, the greater was the radioprotective effect. Compound 4 with a DRF of 1.48 exhibited the highest radioprotective effect. Compounds 2 and 3, having DRF values of 1.17 and 1.18 respectively, were less effective. It should be noted that compounds 3 and 4 have one or two hydroxyl groups on the chromone ring, while compound 2 lacks a hydroxyl group. This observation demonstrated that 2-imino-3-[(chromone-2-yl) carbonyl]thiazolidines have radioprotective activity. Compound 3, having a hydroxyl group at the C-7 position, had the same radioprotective effect as compound 2 without a hydroxyl group. Compound 4, having a hydroxyl group at the C-5 and C-7 positions, slowed a significantly greater radioprotective effect than the other compounds (2 and 3). Therefore, the presence of a hydroxyl group at the C-5 position is important for the radioprotective effect. This finding is in agreement with others reports that the hydroxyl moiety at the chromone ring enhances the antioxidant and radioprotective effects of flavonoids 7, 14) . The substitution of hydroxyl groups in the chromone ring increases their free-radical scavenging ability by binding heavy metal ions, which are known to catalyze many processes leading to the appearance of free radicals. 7, 10, 19) . It is probable that the hydroxyl group at the C-5 position with the 4-oxo function can chelate metals which may be able to suppress the formation of free radicals that are generated from gamma radiation. WR-2721 administered i.p. gave significant radioprotection to normal tissues. Thirty-day survival was evaluated by treating mice i.p. with 300 mg/kg of drugs 30 min before exposure to irradiation, it had a DRF value of 1.63.Therefore, although WR-2721 is more effective than the newly synthesized chromone derivatives, WR-2721 still had a number of undesirable side effects 20, 21) . The structure of compound 4 is different from WR-2721, but similar to that of natural flavonoids. It had a DRF value of 1.48, close to that of WR-2721. Although we have not yet obtained the LD50/30 and DRF values of the compound which has an OH group at C-5 and a H at C-7, the presence of a hydroxyl group at the C-5 position is probably more important than the thiol for radioprotection. The thiol seems to be the major toxic principle of sulfur-containing protectors; also, cysteine thiol is the a toxic mediator 22) . This agent probably has a lower side effects than WR-2721 because its structure is similar to that of natural flavonoids. In conclusion, the combination of a chromone ring with 2-aminothiazoline resulted in 2-imino-3-[(chromone-2-yl)carbonyl]thiazolidines with moderate-to-good radioprotective activities. The most active derivative was compound 4, having hydroxyl groups at the C-5 and C-7 positions of the chromone ring.
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